Herbas VPB

Print
EN | LT
LT - 2,4-di(fenilamino)-pirimidinai, naudingi neoplastinių ligų, uždegiminių ir imuninės sistemos sutrikimų gydyme
EN - 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

Legal status

Patent expired

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 239/48 (2006.01)
C07D 405/12 (2006.01)
C07D 403/12 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
A61K 31/506 (2006.01)
A61K 35/00 (2006.01)
A61P 37/00 (2006.01)
A61P 29/00 (2006.01)
C07D 405/14 (2006.01)
European patent
(11) Number of the document 2275413
(13) Kind of document T
(96) European patent application number 10009414.3
Date of filing the European patent application 2004-03-12
(97) Date of publication of the European application 2011-01-19
(45) Date of publication and mention of the grant of the patent 2013-03-06
(46) Date of publication of the claims translation 2013-07-25
Priority applications
(30) Number Date Country code
0305929 2003-03-14 GB
0319227 2003-08-15 GB
0322370 2003-09-24 GB
Inventors
(72)
Garcia-Echeverria, Carlos, CH
Kanazawa, Takanori, JP
Kawahara, Eiji, JP
Masuya, Keiichi, CH
Matsuura, Naoko, JP
Miyake, Takahiro, JP
Ohmori, Osamu, JP
Umemura, Ichiro, JP
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) 2,4-di(fenilamino)-pirimidinai, naudingi neoplastinių ligų, uždegiminių ir imuninės sistemos sutrikimų gydyme
  2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
Last renewal fee
Payment date Validity (years) Amount
2023-03-07 347.00 EUR